Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain
- 1 April 2010
- journal article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 22 (4), 424-e96
- https://doi.org/10.1111/j.1365-2982.2009.01458.x
Abstract
Opioids are used increasingly in the management of moderate-to-severe chronic non-cancer pain (CNCP). Opioid-induced bowel disorders (OBD) markedly impact health-related quality of life (HRQoL) and frequently limit medically indicated opioid pharmacotherapy. We assessed the risk factors, and effect of OBD on HRQoL in CNCP patients. We also estimated the likely prevalence of narcotic bowel syndrome (NBS). These effects have been reported in cancer patients but not in CNCP previously. Ambulatory CNCP patients (n = 146) taking regularly scheduled opioids were invited to complete the Bowel-Disease-Questionnaire and a pain-sensitive HRQoL instrument. The Rome-II criteria were used to define bowel disorders. Narcotic bowel syndrome was defined as presence of daily severe to very-severe abdominal pain of more than 3 months duration requiring more than 100 mg of morphine equivalent per day. Ninety-eight patients (69%) returned the survey. Respondents had taken opioids for 10 days to 10 years (median 365 days) at a median daily dose of 127.5 mg morphine-equivalent (range 7.5-600 mg). Constipation prevalence was 46.9% (95% CI 36.8-57.3), nausea 27% (95% CI 17.2-35.3), vomiting 9% (95% CI 17.2-35.3), and gastro-esophageal reflux disease 33% (95% CI 23.5-42.9). Chronic abdominal pain was reported by 58.2% (95% CI 53.2-73.9) and 6.4%, (95% CI 2.4-13.5) fulfilled the criteria of NBS. Prevalence of constipation increased with duration of treatment. Health-related quality of life was low in patients with chronic abdominal pain. Bowel disorders including chronic abdominal pain and NBS are common in patients taking opioids for CNCP. Decreased HRQoL in patients with CNCP is driven by chronic abdominal pain.Keywords
This publication has 28 references indexed in Scilit:
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)Pain Medicine, 2009
- Trends in use of opioids for non-cancer pain conditions 2000–2005 in Commercial and Medicaid insurance plans: The TROUP studyPain, 2008
- The Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and ManagementClinical Gastroenterology and Hepatology, 2007
- Opioids in chronic non-cancer pain: systematic review of efficacy and safetyPain, 2004
- Lost Productive Time and Cost Due to Common Pain Conditions in the US WorkforceJama-Journal Of The American Medical Association, 2003
- Opioid-Induced Bowel DysfunctionDrugs, 2003
- The Impact of Pain Management on Quality of LifeJournal of Pain and Symptom Management, 2002
- Incidence, Prevalence, and Management of Opioid Bowel DysfunctionThe American Journal of Surgery, 2001
- A case of narcotic bowel syndrome successfully treated with clonidinePublished by Oxford University Press (OUP) ,1994
- EditorialJournal of Clinical Gastroenterology, 1989